Location: Home
  • search
  • go
  • Relate News
  • 3/21/2023Review of Chinese Drug Registration Application and Evaluation in 2022
  • 3/21/2023Bayer, Orion's Nubeqa Gets Approval in China for Expanded Use in Prost...
  • 3/21/2023CDE Issues the Technical Guidelines for Clinical Research and Developm...
  • 3/21/2023CDE Issues the Technical Guidelines for Writing of Pharmacy Informatio...
  • 3/21/2023CDE Issues the Technical Guidelines for Continuous Manufacturing of Ch...
  • 3/21/2023Therapeutic Antibody Licensing Deals in China: A 2022 End-Of-Year Summ...
  • 3/20/2023New Report: China Cell Therapy Market Opportunity & Clinical Trials In...
  • 3/20/2023TOT Biopharm Terminates Development of Its HER2 ADC TAA013 in China Du...
  • 3/17/2023BeiGene Drops Licensing Option for Leap Thera's I/O Candidate DKN-01
  • 3/17/2023J&J and Legend Shelve Carvykti's UK Launch amid Manufacturing Shortfa...
  • 3/17/2023CDE Solicits Comments on Draft Implementation Suggestions and Chinese ...
  • 3/17/2023CDE Issues the Technical Guidelines for Clinical Trial of Compound Che...
  • 3/17/2023CDE Issues the Guidelines for Safety Information Summary, Analysis and...
  • 3/17/2023CDE Issues the FAQs for Rapid Reporting of Safety Data During Drug Cli...
  • 3/17/2023CDE Issues the Technical Guidelines for Abuse Prevention Pharmaceutica...
  • 3/17/2023Recent Executive Moves
  • 3/17/2023Jinyao Pharma Fined CNY 28M for Abuse of Market Dominance to Sell Chem...
  • 3/17/2023Drug R&D and Product Registration News Digest March 2023 (3)
  • 3/17/2023Upgrading Medtech Commercial Operations in China (McKinsey)
  • 3/16/2023China Biotech Fundraising Up Sharply in February as Six Drugmakers Iss...
  • 3/16/2023ArkBio and Calibr Collaborate on Potential First-in-class Drug for Res...
  • 3/16/2023Ahead of Pfizer Takeover, Seagen Quietly Sign Deal for Certain Cell Th...
  • 3/15/2023Deloitte: 2023 China LSHC Investment and M&A Market Outlook
  • 3/15/2023CDE Issues the List of Reference Formulations for GQCE Studies (66th B...
  • 3/15/2023NHSA Issues the Interim Measures for the Regulation of Unannounced Ins...
  • 3/15/2023Two Senior Health Officials under Investigation for Corruption
  • 3/15/2023NBTRC Statistical Report of Primary Brain Tumors Diagnosed in China in...
  • 3/14/2023HUTCHMED Announces Closing of Fruquintinib License to Takeda Outside C...
  • 3/14/2023CDE Issues the List of Reference Formulations for GQCE Studies (65th B...
  • 3/14/2023CDE Issues the Technical Guidelines for Applicability of Single-Arm Cl...
  • Page:132/798 Total number of articles:23926: [First][<<] [130] [131] [132] [133] [134] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group